Cargando…

51130 Risk of Prolonged Opioid Use After Intensive Care Unit Admission

ABSTRACT IMPACT: This is the first examination of risk factors for prolonged opioid use after an ICU stay and will inform efforts to strengthen prescribing guidelines and care transition models for patients after critical illness. OBJECTIVES/GOALS: The majority of patients in intensive care units (I...

Descripción completa

Detalles Bibliográficos
Autores principales: Delaney, Lia D, Kenney, Brooke, Hu, May, Englesbe, Michael, Brummett, Chad, Waljee, Jennifer F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828040/
http://dx.doi.org/10.1017/cts.2021.769
_version_ 1784647776402931712
author Delaney, Lia D
Kenney, Brooke
Hu, May
Englesbe, Michael
Brummett, Chad
Waljee, Jennifer F
author_facet Delaney, Lia D
Kenney, Brooke
Hu, May
Englesbe, Michael
Brummett, Chad
Waljee, Jennifer F
author_sort Delaney, Lia D
collection PubMed
description ABSTRACT IMPACT: This is the first examination of risk factors for prolonged opioid use after an ICU stay and will inform efforts to strengthen prescribing guidelines and care transition models for patients after critical illness. OBJECTIVES/GOALS: The majority of patients in intensive care units (ICU) receive opioids during admission, and up to 25% receive a prescription at discharge. However, transitions of care and prolonged use after discharge remain unknown. We aim to characterize risk factors for prolonged opioid use after an ICU stay. METHODS/STUDY POPULATION: A retrospective study using insurance claims from Optum Clinformatics ®Data Mart was conducted for opioid-naive adult patients (18-64 years) with an ICU admission from 2010 to 2019. The primary outcome was new persistent opioid use, defined as a continued prescription fill 91-180 days after discharge, in addition to a fill in the first 90 days. The primary exposure was an opioid fill at discharge. The ICU admission was characterized using the Clinical Classification System from the Agency of Healthcare Research and Quality, based on patients’primary diagnosis code. Diagnoses were combined into 11 groups highlighting the affected organ system/mechanism of injury. Logistic regression evaluated the associations of patient demographic and clinical characteristics with the probability of persistent opioid use. RESULTS/ANTICIPATED RESULTS: In this cohort of 90,721 patients discharged from the ICU, 3.3% continued to fill opioids at 6 months. An opioid prescription fill (OR 3.1; 95% CI 28 - 3.3) and benzodiazepine prescription fill (OR 1.6; 95% CI 1.4 - 1.8) within 3 days of ICU discharge were each significantly associated with the development of new persistent opioid use. Patient diagnosis groups of Musculoskeletal/Trauma (OR 2.3; 95% CI 2.0 - 2.6), Neoplasms (OR 1.6; 95% CI 1.5 - 1.9), and GI/Hepatobiliary (OR 1.5; 95% CI 1.3 - 1.8) were significantly more likely to develop new persistent use when compared to the Cardiovascular diagnosis group. DISCUSSION/SIGNIFICANCE OF FINDINGS: Opioid prescriptions at discharge after an ICU stay increase the odds of prolonged opioid use. These results will inform efforts to strengthen prescribing guidelines and care models after a critical illness. Further work will characterize the trajectory of prescribing and patient exposure to high-risk prescribing after ICU discharge.
format Online
Article
Text
id pubmed-8828040
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cambridge University Press
record_format MEDLINE/PubMed
spelling pubmed-88280402022-02-28 51130 Risk of Prolonged Opioid Use After Intensive Care Unit Admission Delaney, Lia D Kenney, Brooke Hu, May Englesbe, Michael Brummett, Chad Waljee, Jennifer F J Clin Transl Sci Translational Science, Policy, & Health Outcomes Science ABSTRACT IMPACT: This is the first examination of risk factors for prolonged opioid use after an ICU stay and will inform efforts to strengthen prescribing guidelines and care transition models for patients after critical illness. OBJECTIVES/GOALS: The majority of patients in intensive care units (ICU) receive opioids during admission, and up to 25% receive a prescription at discharge. However, transitions of care and prolonged use after discharge remain unknown. We aim to characterize risk factors for prolonged opioid use after an ICU stay. METHODS/STUDY POPULATION: A retrospective study using insurance claims from Optum Clinformatics ®Data Mart was conducted for opioid-naive adult patients (18-64 years) with an ICU admission from 2010 to 2019. The primary outcome was new persistent opioid use, defined as a continued prescription fill 91-180 days after discharge, in addition to a fill in the first 90 days. The primary exposure was an opioid fill at discharge. The ICU admission was characterized using the Clinical Classification System from the Agency of Healthcare Research and Quality, based on patients’primary diagnosis code. Diagnoses were combined into 11 groups highlighting the affected organ system/mechanism of injury. Logistic regression evaluated the associations of patient demographic and clinical characteristics with the probability of persistent opioid use. RESULTS/ANTICIPATED RESULTS: In this cohort of 90,721 patients discharged from the ICU, 3.3% continued to fill opioids at 6 months. An opioid prescription fill (OR 3.1; 95% CI 28 - 3.3) and benzodiazepine prescription fill (OR 1.6; 95% CI 1.4 - 1.8) within 3 days of ICU discharge were each significantly associated with the development of new persistent opioid use. Patient diagnosis groups of Musculoskeletal/Trauma (OR 2.3; 95% CI 2.0 - 2.6), Neoplasms (OR 1.6; 95% CI 1.5 - 1.9), and GI/Hepatobiliary (OR 1.5; 95% CI 1.3 - 1.8) were significantly more likely to develop new persistent use when compared to the Cardiovascular diagnosis group. DISCUSSION/SIGNIFICANCE OF FINDINGS: Opioid prescriptions at discharge after an ICU stay increase the odds of prolonged opioid use. These results will inform efforts to strengthen prescribing guidelines and care models after a critical illness. Further work will characterize the trajectory of prescribing and patient exposure to high-risk prescribing after ICU discharge. Cambridge University Press 2021-03-30 /pmc/articles/PMC8828040/ http://dx.doi.org/10.1017/cts.2021.769 Text en © The Association for Clinical and Translational Science 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Translational Science, Policy, & Health Outcomes Science
Delaney, Lia D
Kenney, Brooke
Hu, May
Englesbe, Michael
Brummett, Chad
Waljee, Jennifer F
51130 Risk of Prolonged Opioid Use After Intensive Care Unit Admission
title 51130 Risk of Prolonged Opioid Use After Intensive Care Unit Admission
title_full 51130 Risk of Prolonged Opioid Use After Intensive Care Unit Admission
title_fullStr 51130 Risk of Prolonged Opioid Use After Intensive Care Unit Admission
title_full_unstemmed 51130 Risk of Prolonged Opioid Use After Intensive Care Unit Admission
title_short 51130 Risk of Prolonged Opioid Use After Intensive Care Unit Admission
title_sort 51130 risk of prolonged opioid use after intensive care unit admission
topic Translational Science, Policy, & Health Outcomes Science
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828040/
http://dx.doi.org/10.1017/cts.2021.769
work_keys_str_mv AT delaneyliad 51130riskofprolongedopioiduseafterintensivecareunitadmission
AT kenneybrooke 51130riskofprolongedopioiduseafterintensivecareunitadmission
AT humay 51130riskofprolongedopioiduseafterintensivecareunitadmission
AT englesbemichael 51130riskofprolongedopioiduseafterintensivecareunitadmission
AT brummettchad 51130riskofprolongedopioiduseafterintensivecareunitadmission
AT waljeejenniferf 51130riskofprolongedopioiduseafterintensivecareunitadmission